Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resected Pancreatic Adenocarcinoma”

134 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 134 results

Not applicableLooking for participantsNCT04571294
What this trial is testing

Para-aortic Lymphnodes Removal During Upfront Pancreaticoduodenectomy

Who this might be right for
Pancreas CancerPancreaticoduodenal LymphadenopathyPancreas Adenocarcinoma
Humanitas Hospital, Italy 180
Testing effectiveness (Phase 2)WithdrawnNCT00253526
What this trial is testing

Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the PancreasRecurrent Pancreatic CancerStage I Pancreatic Cancer+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Study completedNCT00203892
What this trial is testing

Study of CAP1-6D in Patients With Locally Advanced or Surgically Resected Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma
University of Chicago 23
Not applicableLooking for participantsNCT07148830
What this trial is testing

Mesopancreatic Excision for Pancreatic Duct Adenocarcinoma.

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
Minia University 100
Testing effectiveness (Phase 2)Study completedNCT00191568
What this trial is testing

Gemcitabine, Oxaliplatin and Radiotherapy in Treating Patients With Completely Resected Pancreatic Cancer

Who this might be right for
Pancreatic Neoplasms
Eli Lilly and Company 45
Early research (Phase 1)Ended earlyNCT02714374
What this trial is testing

GL-ONC1 Administered Intravenously Prior to Surgery to Patients With Solid Organ Cancers

Who this might be right for
Solid Organ Cancers
Andrew Lowy 5
Not applicableStudy completedNCT01278368
What this trial is testing

Effect Of Preoperative Chemotherapy On Short-Term Outcome After Pancreatic Resection

Who this might be right for
Locally Advanced Pancreatic Adenocarcinoma
Università Vita-Salute San Raffaele 150
Not applicableStudy completedNCT06980792
What this trial is testing

Surgical Approach for Adenocarcinoma of the Pancreas With Synchronous Liver Metastases

Who this might be right for
Pancreas NeoplasmsLiver MetastasisPancreas Ductal Adenocarcinoma+3 more
Azienda Ospedaliero-Universitaria di Modena 90
Testing effectiveness (Phase 2)Study completedNCT02481635
What this trial is testing

Gemcitabine/Nab-paclitaxel and Radiation Therapy Followed by Surgery in Patients With Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University Health Network, Toronto 11
Not applicableNot Yet RecruitingNCT05611359
What this trial is testing

Surgery and Thermal Hepatic Ablation Combined With Chemotherapy in Hepatic Oligometastatic Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Second Affiliated Hospital, Zhejiang University, School of Medicine 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT05968326
What this trial is testing

The Efficacy and Safety of Adjuvant Autogene Cevumeran Plus Atezolizumab and mFOLFIRINOX Versus mFOLFIRINOX Alone in Participants With Resected PDAC

Who this might be right for
Adenocarcinoma, Pancreatic Ductal
Genentech, Inc. 260
Not applicableUnknownNCT04737551
What this trial is testing

Adjuvant Chemoradiation Following Radical Resection of Pancreatic Ductal Adenocarcinoma, a Prospective Cohort Study

Who this might be right for
Resectable Pancreatic CancerAdjuvant ChemoradiotherapySurgery
Shanghai Zhongshan Hospital 400
Not applicableStudy completedNCT00918853
What this trial is testing

Prospective Evaluation of the Resection Margins and the Ganglionic Status Using a Quality Standard Resection for Adenocarcinoma of the Head of the Pancreas

Who this might be right for
PancreasAdenocarcinoma
Institut Paoli-Calmettes 156
Testing effectiveness (Phase 2)Study completedNCT01595321
What this trial is testing

Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas

Who this might be right for
Pancreatic Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 19
Testing effectiveness (Phase 2)Study completedNCT00068575
What this trial is testing

Chemotherapy, Interferon Alfa, and Radiation Therapy in Treating Patients Who Have Undergone Surgery For Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 29
Early research (Phase 1)Ended earlyNCT01025570
What this trial is testing

A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
University of California, San Francisco 3
Not applicableUnknownNCT03570502
What this trial is testing

Incidence of POPF in the Resection of the Left Pancreas With RFAT

Who this might be right for
Pancreas NeoplasmPancreas CancerPancreatic Adenocarcinoma+1 more
Hospital del Mar 38
Not applicableUnknownNCT05714475
What this trial is testing

Pancreas Resection for Colorectal Metastasis: Retrospective Study

Who this might be right for
Pancreas MetastasesColorectal Cancer
Ospedale Generale Di Zona Moriggia-Pelascini 15
Testing effectiveness (Phase 2)Ended earlyNCT02031536
What this trial is testing

Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery

Who this might be right for
GastrinomaGlucagonomaInsulinoma+4 more
ECOG-ACRIN Cancer Research Group 2
Testing effectiveness (Phase 2)Looking for participantsNCT06048484
What this trial is testing

Combination Therapy in Patients With Localized Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Gulam Manji 60
Next Page